Company: CRESW
Filing Date: 2025-10-24
Form Type: 20-F
Source: 0001654954-25-012195
Chunk: 371

Company: CRESUD INC
Filing Date: 2025-10-24
Form: 20-F
Item: Item 7
Chunk 371
---
 Consulting Agreement, we pay Consultores Asset Management S.A. for its services, an annual fee equal to 10% of our annual after-tax net income. During the fiscal years 2025, 2024 and 2023 were recognized ARS 9,081 million, ARS 12,945 million and ARS 24,823 million, respectively.

The Consulting Agreement is subject to termination by either party upon not less than 60 days prior written notice. If we terminate the Consulting Agreement without cause, we will be liable to Consultores Asset Management S.A. and/or CVCU for twice the average of the amounts of the management fee paid to Consultores Asset Management S.A. for the two fiscal years prior to such termination.

Loan between Tyrus S.A. and Yad Leviim Ltd.

On May 3, 2024, an extension was reported for a period of 3 years, of a loan granted by Tyrus S.A., a company wholly owned by IRSA, to Yad Leviim Ltd., in a principal amount of USD 16,2 million at a rate interest of 7% per year from March 23, 2024. Yad Leviim Ltd. is a company controlled by Eduardo Elsztain.

208
Investment in Golden Juniors Segregated Portfolio

On August 29, 2025, IRSA approved an investment of up to USD 12 million, in cash or in kind, in Golden Juniors Segregated Portfolio, an investment fund composed of different segregated portfolios, whose investment manager is a company directly controlled by Mr. Eduardo Sergio Elsztain, Chairman of IRSA.

This investment is made with the purpose of diversifying part of IRSA’s liquidity into financial alternatives that allow capturing growth opportunities in emerging sectors of the Argentine economy, particularly in the field of precious metals and the mining industry.

As part of the investment agreement, it was established that IRSA and/or its subsidiaries will not pay performance fees, being required only to bear the proportion of expenses corresponding to their participation in the fund.

The execution of this trust agreement has been approved by the Board of Directors of IRSA, with no objections from the Audit. 

For further information regarding related party transactions see Note 30 to our Audited Consolidated Financial Statements.

C. Interests of Experts and Counsel

This section is not applicable.